SUBSCRIBE
SUBSCRIBE
News   Deals

QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)

October 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- Canadian eye-care company QLT Inc said it restructured its pact with Novartis Pharma AG, giving it exclusive rights to sell anti-blindness treatment Visudyne in the United States.
Mergers & acquisitions
MORE ON THIS TOPIC
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Pictured: Bristol Myers Squibb office in California
ALS
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line
October 15, 2025
 · 
1 min read
 · 
Tristan Manalac
Creative poster collage of two business partners having deal financial payment giving money banknote isolated on beige color background.
Mergers & acquisitions
BioCryst Snaps Up Fellow Angiodema Player Astria for $700M
October 15, 2025
 · 
2 min read
 · 
Tristan Manalac